A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
Pfizer
Hoffmann-La Roche
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Pfizer
Servicio de Salud Metropolitano Sur Oriente
Goethe University